Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Endovascular Stent Grafts Market between 2026 and 2030?

The endovascular stent grafts market has observed rapid expansion in its size over recent years. It is anticipated to expand from $1.45 billion in 2025 to $1.99 billion in 2026, achieving a compound annual growth rate (CAGR) of 37.9%. The drivers behind this historical growth include reliance on conventional open surgical procedures, limited availability of advanced stent graft materials, the growing prevalence of vascular diseases, early adoption of coronary and peripheral grafts, and increasing awareness of aortic aneurysm treatments.

The endovascular stent grafts market is projected to experience rapid expansion in the coming years. This market is anticipated to reach $7.13 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 37.5%. This projected growth is driven by factors such as technological advancements in endovascular stent grafts, an increase in minimally invasive surgical procedures, a rise in aortic aneurysm and dissection incidents, greater uptake of hybrid vascular grafts, and the expansion of cardiovascular healthcare infrastructure. Key trends during this forecast period encompass the growing acceptance of minimally invasive endovascular techniques, heightened demand for personalized stent grafts, progress in hybrid and biologic graft materials, the broader application of thoracic and abdominal aortic repair procedures, and an increased emphasis on patient safety and regulatory adherence.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20549&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Endovascular Stent Grafts Market?

The rising occurrence of cardiovascular ailments is anticipated to drive the expansion of the endovascular stent graft market in the future. Cardiovascular disease, or CVD, encompasses a category of conditions affecting the heart and blood vessels. This growing incidence of cardiovascular diseases stems from a confluence of lifestyle decisions, existing medical conditions, inherited predispositions, and environmental influences. Endovascular stent grafts present a significant treatment alternative for cardiovascular diseases, emphasizing reduced invasiveness and enhanced patient recovery. By strengthening compromised vessel walls, these stent grafts prevent rupture and mitigate the potential for severe, life-threatening complications. As an illustration, in October 2025, the Australian Institute Of Health And Welfare, an Australia-based government agency, stated that in 2023, approximately 57,100 adults aged 25 and above suffered acute coronary events, equating to about 156 daily incidents. Consequently, the surge in cardiovascular diseases is a key factor propelling the expansion of the endovascular stent grafts market.

What Segments Are Included Within The Endovascular Stent Grafts Market?

The endovascular stent grafts market covered in this report is segmented –

1) By Product: Hemodialysis Access Grafts, Endovascular Stent Grafts, Coronary Artery By-Pass Grafts, Vascular Grafts For Aorta Disease, Peripheral Vascular Grafts

2) By Raw Material: Synthetic Vascular Grafts, Biological Vascular Grafts, Hybrid Vascular Grafts

3) By Application: Cardiac Aneurysm, Kidney Failure, Vascular Occlusion, Coronary Artery Disease

Subsegments:

1) By Hemodialysis Access Grafts: Arteriovenous (AV) Fistula Grafts, Synthetic Hemodialysis Access Grafts, Bioengineered Hemodialysis Access Grafts, Coated Hemodialysis Grafts, Endovascular Hemodialysis Grafts

2) By Endovascular Stent Grafts: Aneurysm Stent Grafts, Stent Grafts For Aortic Dissection, Thoracic Endovascular Stent Grafts, Abdominal Endovascular Stent Grafts, Biliary Endovascular Stent Grafts

3) By Coronary Artery By-Pass Grafts: Saphenous Vein Grafts (SVG), Arterial Coronary Bypass Grafts, Endovascular Coronary Artery Bypass Grafts (CABG), Synthetic Coronary Bypass Grafts

4) By Vascular Grafts For Aorta Disease: Endovascular Aortic Stent Grafts, Aortic Aneurysm Grafts, Aortic Bypass Grafts, Thoracoabdominal Aortic Stent Grafts, Aortic Dissection Stent Grafts

5) By Peripheral Vascular Grafts: Carotid Artery Stent Grafts, Femoral Artery Stent Grafts, Popliteal Artery Stent Grafts, Iliac Artery Stent Grafts, Peripheral Endovascular Stent Grafts

Which Trends Are Expected To Influence The Endovascular Stent Grafts Market In The Upcoming Years?

Companies operating in the endovascular stent grafts market are primarily focused on developing novel products like the thoracic aortic stent-graft. The goal is to enhance the precision and efficacy of treatment for thoracic aortic aneurysms and dissections, improve patient outcomes, and address complex anatomical challenges through advanced technology and design improvements. A thoracic aortic stent graft is a specialized medical device utilized in endovascular surgery to treat conditions and diseases of the thoracic aorta, the section of the aorta situated in the chest, providing a blend of safety, effectiveness, and convenience for managing thoracic aortic diseases. For instance, in February 2024, Endovastec, a medical device company based in China, unveiled the Multi-Branch Thoracic Aortic Stent-Graft System (Hector) and completed its initial clinical application in Switzerland. The Hector system represents a significant progression in endovascular stent graft technology, as its multi-branch design facilitates the treatment of complex thoracic aortic conditions by accommodating and preserving essential branches of the aorta, such as the arteries that supply vital organs.

Who Are The Major Companies Operating In The Endovascular Stent Grafts Market?

Major companies operating in the endovascular stent grafts market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Terumo Corporation, Cook Group Incorporated, Merit Medical Systems Inc., Biotronik SE & Co KG, MicroPort Scientific Corporation, Endologix LLC, LeMaitre Vascular Inc., Lifetech Scientific Corporation, W. L. Gore & Associates Inc., Braile Biomedica, BrosMed Medical BV, Micro Interventional Devices Inc. (MID), Lombard Medical Inc., Endovastec Medical Technology Co Ltd., Jotec GmbH, Bentley InnoMed GmbH, Bolton Medical Inc., Alvimedica, Endospan Ltd., Vivasure Medical Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/endovascular-stent-grafts-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Endovascular Stent Grafts Market?

North America was the largest region in the endovascular stent grafts market in 2025. The regions covered in the endovascular stent grafts market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Endovascular Stent Grafts Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20549&type=smp

Browse Through More Reports Similar to the Global Endovascular Stent Grafts Market 2026, By The Business Research Company

Embolization Coils Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/embolization-coils-global-market-report

Aortic Aneurysm Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/aortic-aneurysm-global-market-report

Aortic Aneurysm Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/aortic-aneurysm-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company